Massachusetts is Latest State to Enact Biosimilar Substitution Law

Generic Line
Massachusetts has become the eighth state to pass a law enabling pharmacists to substitute a biosimilar for a branded biological product, earning praise from industry groups that believe such state laws are vital to biosimilar adoption.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00